Certain ergot peptide alkaloids administered to the nasal mucosa

Details Certain ergot peptide alkaloids administered to the nasal mucosa Certain ergot peptide alkaloids administered to the nasal mucosa

1986-06-09

1988-07-19

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

514250, A61K 914

Patent

active

047584238

ABSTRACT:
The present invention provides a nasal pharmaceutical composition comprising as active agent a compound of formula I, ##STR1## wherein R.sub.1 is hydrogen or halogen,

REFERENCES:
patent: 3752814 (1973-08-01), Fluckiger et al.
patent: 3752888 (1973-08-01), Fluckiger et al.
patent: 3772299 (1973-11-01), Stadler et al.
patent: 3901891 (1975-08-01), Fehr et al.
patent: 4076715 (1978-02-01), Fehr et al.
patent: 4462983 (1984-07-01), Azria et al.
Bradfield, Curr. Ther., 17, No. 11, 37-40, 1976.
Wilkinson, Brit. Med. J. 1971/2, pp. 754-755.
Graham et al.-New Eng. J. Of Med. 10/20/60, pp. 802-804.
Monthly Index of Med. Specialties (MIMS), 1974, pp. 44, 49 & 50.

Affiliated with

Also associated with

Rating

Certain ergot peptide alkaloids administered to the nasal mucosa does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Certain ergot peptide alkaloids administered to the nasal mucosa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain ergot peptide alkaloids administered to the nasal mucosa will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-596518